Adamek RJ et al. |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection. |
1995 |
Am. J. Gastroenterol. |
pmid:7801936
|
Jaup BH and Norrby A |
Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. |
1995 |
Am. J. Gastroenterol. |
pmid:7771426
|
Isomoto H et al. |
Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. |
2005 |
Am. J. Gastroenterol. |
pmid:16086706
|
Pamuk ON et al. |
Are Turkish Helicobacter pylori strains gaining resistance against clarithromycin? |
2000 |
Am. J. Gastroenterol. |
pmid:10926000
|
Schaeverbeke T et al. |
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study. |
2005 |
Am. J. Gastroenterol. |
pmid:16393213
|
de Bortoli N et al. |
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. |
2007 |
Am. J. Gastroenterol. |
pmid:17313499
|
Mohar A et al. |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. |
2002 |
Am. J. Gastroenterol. |
pmid:12385434
|
De Francesco V et al. |
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia? |
2002 |
Am. J. Gastroenterol. |
pmid:12385470
|
Chey WD and Wong BC |
American College of Gastroenterology guideline on the management of Helicobacter pylori infection. |
2007 |
Am. J. Gastroenterol. |
pmid:17608775
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Cremonini F et al. |
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. |
2002 |
Am. J. Gastroenterol. |
pmid:12425542
|
Peterson WL et al. |
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. |
1993 |
Am. J. Gastroenterol. |
pmid:8237933
|
van Zanten SV and Thompson K |
Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection? |
2006 |
Am. J. Gastroenterol. |
pmid:16863548
|
Froehlich F et al. |
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. |
2001 |
Am. J. Gastroenterol. |
pmid:11513170
|
Rokkas T et al. |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment. |
2006 |
Am. J. Gastroenterol. |
pmid:16928256
|
Sánchez-Delgado J et al. |
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. |
2008 |
Am. J. Gastroenterol. |
pmid:18564109
|
Lazzaroni M et al. |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. |
1997 |
Am. J. Gastroenterol. |
pmid:9128316
|
Sapone A et al. |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management. |
2003 |
Am. J. Gastroenterol. |
pmid:12809821
|
Zhou L et al. |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. |
2014 |
Am. J. Gastroenterol. |
pmid:24642580
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Levy M et al. |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. |
2002 |
Am. J. Gastroenterol. |
pmid:11866264
|
Christopher K et al. |
Clarithromycin use preceding fulminant hepatic failure. |
2002 |
Am. J. Gastroenterol. |
pmid:11866297
|
Narayani RI et al. |
Resolution of collagenous colitis after treatment for Helicobacter pylori. |
2002 |
Am. J. Gastroenterol. |
pmid:11866305
|
Gisbert JP et al. |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. |
2006 |
Am. J. Gastroenterol. |
pmid:16454825
|
Vakil N et al. |
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. |
1998 |
Am. J. Gastroenterol. |
pmid:9732920
|
Chu KM et al. |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. |
1998 |
Am. J. Gastroenterol. |
pmid:9732921
|
Lamouliatte H et al. |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. |
1998 |
Am. J. Gastroenterol. |
pmid:9732938
|
Hsu PI et al. |
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. |
2005 |
Am. J. Gastroenterol. |
pmid:16279889
|
Vakil N |
Helicobacter pylori: factors affecting eradication and recurrence. |
2005 |
Am. J. Gastroenterol. |
pmid:16279890
|
Sullivan B et al. |
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. |
2002 |
Am. J. Gastroenterol. |
pmid:12385435
|
Gisbert JP et al. |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. |
2008 |
Am. J. Gastroenterol. |
pmid:17764498
|
Forné M et al. |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. |
1995 |
Am. J. Gastroenterol. |
pmid:7733075
|
Lerang F et al. |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? |
1997 |
Am. J. Gastroenterol. |
pmid:9040200
|
Chey WD et al. |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. |
1997 |
Am. J. Gastroenterol. |
pmid:9317068
|
Ozmen MM and Johnson CD |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication? |
1995 |
Am. J. Gastroenterol. |
pmid:7661197
|
Savarino V et al. |
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. |
1995 |
Am. J. Gastroenterol. |
pmid:7717343
|
Zullo A et al. |
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study. |
1997 |
Am. J. Gastroenterol. |
pmid:9362185
|
Sirimontaporn N et al. |
Ten-day sequential therapy of Helicobacter pylori infection in Thailand. |
2010 |
Am. J. Gastroenterol. |
pmid:20010919
|
Basu PP et al. |
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. |
2011 |
Am. J. Gastroenterol. |
pmid:21989146
|
Hasegawa T et al. |
Image of the month: Disseminated Nontuberculous Mycobacteriosis. |
2015 |
Am. J. Gastroenterol. |
pmid:26673493
|
Schwartz H et al. |
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. |
1998 |
Am. J. Gastroenterol. |
pmid:9576452
|
Santander C et al. |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. |
1996 |
Am. J. Gastroenterol. |
pmid:8759659
|
Tursi A et al. |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication. |
1996 |
Am. J. Gastroenterol. |
pmid:8759696
|
Jarbol DE et al. |
Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. |
2006 |
Am. J. Gastroenterol. |
pmid:16771937
|
Bytzer P |
Management of the dyspeptic patient: anything goes? |
2006 |
Am. J. Gastroenterol. |
pmid:16771938
|
Manes G et al. |
Eradication of Helicobacter pylori and dosages of esomeprazole. |
2006 |
Am. J. Gastroenterol. |
pmid:16771971
|
Laine L et al. |
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. |
2000 |
Am. J. Gastroenterol. |
pmid:11151867
|
Nakao K et al. |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. |
1997 |
Am. J. Gastroenterol. |
pmid:9177520
|
Maconi G et al. |
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? |
2001 |
Am. J. Gastroenterol. |
pmid:11232676
|
Chey WD et al. |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. |
2017 |
Am. J. Gastroenterol. |
pmid:28071659
|